Nitroxyl, redox switches, cardiac myofilaments, and heart failure: a prequel to novel therapeutics?
- PMID: 23023505
- PMCID: PMC3494458
- DOI: 10.1161/CIRCRESAHA.112.278416
Nitroxyl, redox switches, cardiac myofilaments, and heart failure: a prequel to novel therapeutics?
Figures
Comment on
-
Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function.Circ Res. 2012 Sep 28;111(8):1002-11. doi: 10.1161/CIRCRESAHA.112.270827. Epub 2012 Jul 31. Circ Res. 2012. PMID: 22851540 Free PMC article.
References
-
- Mudd JO, Kass DA. Tackling heart failure in the twenty-first century. Nature. 2008;451:919–928. - PubMed
-
- Hasenfuss G, Teerlink JR. Cardiac inotropes: Current agents and future directions. European Heart Journal. 2011;32:1838–U1835. - PubMed
-
- Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, Kemp-Harper BK. Nitroxyl (hno): The cinderella of the nitric oxide story. Trends in Pharmacological Sciences. 2008;29:601–608. - PubMed
-
- Miranda KM. The chemistry of nitroxyl (hno) and implications in biology. Coordination Chemistry Reviews. 2005;249:433–455.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
